Vivos Therapeutics (NASDAQ:VVOS) is set to raise approximately $4 million through a private placement offering. The company will issue 980,393 shares to an institutional investor at a price of $4.08 per share. Additionally, the investor will receive a five-year Series A Warrant to purchase up to the same number of common stock shares and an 18-month Series B Warrant for the same number of shares, each with an exercise price of $3.83 per share. The private placement is expected to close around November 2, 2023. Vivos plans to utilize the net proceeds for general corporate purposes.
The Markets by Proactive
Go to Proactive Australia
Proactive’s Australian coverage continues on .com